Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delia Goletti

Showing results (111-120 of 310) with videos related to

Pageof 31
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
Lack of CD27-CD45RA-V gamma 9V delta 2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosisCristiana Gioia, Chiara Agrati, Rita Casetti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining conditionAntonella Cingolani, Alessandro Cozzi Lepri, Antonella Castagna, et al.
The European Respiratory Journal|November 13, 2016
Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosisElisa Petruccioli, Thomas J Scriba, Linda Petrone, et al.
International Journal of Mycobacteriology|January 4, 2017
Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kitElisa Petruccioli, Teresa Chiacchio, Ilaria Pepponi, et al.
The Journal of Infection|October 9, 2016
First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB PlusElisa Petruccioli, Teresa Chiacchio, Ilaria Pepponi, et al.
The Journal of Infectious Diseases|August 29, 2002
Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vgamma9Vdelta2 T cells in chronically infected patients undergoing structured treatment interruptionFederico Martini, Fabrizio Poccia, Delia Goletti, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 29, 2006
Innate anti-viral immunity is associated with the protection elicited by the simian immunodeficiency virus (SIV) live attenuated virus vaccine in cynomolgus monkeysDelia Goletti, Iole Macchia, Pasqualina Leone, et al.
Respiratory Research|January 30, 2007
Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot studyDelia Goletti, M Pasquale Parracino, Ornella Butera, et al.
Journal of Clinical Medicine|June 2, 2021
Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort StudyValeria Belleudi, Alessandro C Rosa, Francesca R Poggi, et al.
Le Infezioni in Medicina|September 23, 2022
Impact of SARS-CoV-2 infection on tuberculosis outcome and follow-up in Italy during the first COVID-19 pandemic wave: a nationwide online surveyDiana Canetti, Roberta Maria Antonello, Laura Saderi, et al.
Pageof 31

Showing results (111-120 of 310) with videos related to

Sort By:
Pageof 31
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
Lack of CD27-CD45RA-V gamma 9V delta 2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosisCristiana Gioia, Chiara Agrati, Rita Casetti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining conditionAntonella Cingolani, Alessandro Cozzi Lepri, Antonella Castagna, et al.
The European Respiratory Journal|November 13, 2016
Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosisElisa Petruccioli, Thomas J Scriba, Linda Petrone, et al.
International Journal of Mycobacteriology|January 4, 2017
Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kitElisa Petruccioli, Teresa Chiacchio, Ilaria Pepponi, et al.
The Journal of Infection|October 9, 2016
First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB PlusElisa Petruccioli, Teresa Chiacchio, Ilaria Pepponi, et al.
The Journal of Infectious Diseases|August 29, 2002
Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vgamma9Vdelta2 T cells in chronically infected patients undergoing structured treatment interruptionFederico Martini, Fabrizio Poccia, Delia Goletti, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 29, 2006
Innate anti-viral immunity is associated with the protection elicited by the simian immunodeficiency virus (SIV) live attenuated virus vaccine in cynomolgus monkeysDelia Goletti, Iole Macchia, Pasqualina Leone, et al.
Respiratory Research|January 30, 2007
Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot studyDelia Goletti, M Pasquale Parracino, Ornella Butera, et al.
Journal of Clinical Medicine|June 2, 2021
Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort StudyValeria Belleudi, Alessandro C Rosa, Francesca R Poggi, et al.
Le Infezioni in Medicina|September 23, 2022
Impact of SARS-CoV-2 infection on tuberculosis outcome and follow-up in Italy during the first COVID-19 pandemic wave: a nationwide online surveyDiana Canetti, Roberta Maria Antonello, Laura Saderi, et al.
Pageof 31